Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Obstructive Lung Diseases

  Free Subscription


Articles published in Respir Med

Retrieve available abstracts of 158 articles:
HTML format
Text format



Single Articles


    May 2017
  1. SCHOR D, Rizzo JA, Medeiros D, Dela Bianca AC, et al
    Home-made spacer as an auxiliary device in administration of beclomethasone via pressurized metered dose inhaler for asthma control. A randomized controlled pragmatic trial.
    Respir Med. 2017;126:52-58.
    PubMed     Text format     Abstract available


  2. BREUER O, Daum H, Cohen-Cymberknoh M, Unger S, et al
    Autosomal dominant gain of function STAT1 mutation and severe bronchiectasis.
    Respir Med. 2017;126:39-45.
    PubMed     Text format     Abstract available


  3. NELSEN LM, Kimel M, Murray LT, Ortega H, et al
    Qualitative evaluation of the St George's Respiratory Questionnaire in patients with severe asthma.
    Respir Med. 2017;126:32-38.
    PubMed     Text format     Abstract available


  4. FERRER GALVAN M, Javier Alvarez Gutierrez F, Romero Falcon A, Romero Romero B, et al
    Is the bronchodilator test an useful tool to measure asthma control?
    Respir Med. 2017;126:26-31.
    PubMed     Text format     Abstract available


  5. ADACHI M, Goldfrad C, Jacques L, Nishimura Y, et al
    Corrigendum to "Efficacy and safety comparison: Fluticasone furoate and fluticasone propionate, after step down from fluticasone furoate/vilanterol in Japanese patients with well-controlled asthma, a randomized trial" [Respir. Med. 120 (November 2016)
    Respir Med. 2017;126:25.
    PubMed     Text format    


    April 2017
  6. NADEAU M, Boulay ME, Milot J, Lepage J, et al
    Comparative prevalence of co-morbidities in smoking and non-smoking asthma patients with incomplete reversibility of airway obstruction, non-smoking asthma patients with complete reversibility of airway obstruction and COPD patients.
    Respir Med. 2017;125:82-88.
    PubMed     Text format     Abstract available


  7. RASTOGI D, Jung M, Strizich G, Shaw PA, et al
    Association of systemic inflammation, adiposity, and metabolic dysregulation with asthma burden among Hispanic adults.
    Respir Med. 2017;125:72-81.
    PubMed     Text format     Abstract available


  8. AKIKI Z, Rava M, Diaz Gil O, Pin I, et al
    Serum cytokine profiles as predictors of asthma control in adults from the EGEA study.
    Respir Med. 2017;125:57-64.
    PubMed     Text format     Abstract available


  9. JEONG A, Imboden M, Hansen S, Zemp E, et al
    Heterogeneity of obesity-asthma association disentangled by latent class analysis, the SAPALDIA cohort.
    Respir Med. 2017;125:25-32.
    PubMed     Text format     Abstract available


    March 2017
  10. DATTA S, Nam HS, Hayashi M, Maldonado L, et al
    Expression of GULP1 in bronchial epithelium is associated with the progression of emphysema in chronic obstructive pulmonary disease.
    Respir Med. 2017;124:72-78.
    PubMed     Text format     Abstract available


  11. TIWARI A, Rahman K, Abejie B, Jain VV, et al
    Longer duration of asthma is significantly associated with increased RV/TLC ratio.
    Respir Med. 2017;124:44-48.
    PubMed     Text format     Abstract available


  12. MANSUR AH, Srivastava S, Mitchell V, Sullivan J, et al
    Longterm clinical outcomes of omalizumab therapy in severe allergic asthma: Study of efficacy and safety.
    Respir Med. 2017;124:36-43.
    PubMed     Text format     Abstract available


  13. VON BULOW A, Backer V, Bodtger U, Soes-Petersen NU, et al
    The level of diagnostic assessment in severe asthma: A nationwide real-life study.
    Respir Med. 2017;124:21-29.
    PubMed     Text format     Abstract available


    February 2017
  14. SILVERMAN RA, Hasegawa K, Egan DJ, Stiffler KA, et al
    Multicenter study of cigarette smoking among adults with asthma exacerbations in the emergency department, 2011-2012.
    Respir Med. 2017 Feb 7. pii: S0954-6111(17)30025.
    PubMed     Text format     Abstract available


  15. VEIDAL S, Jeppegaard M, Sverrild A, Backer V, et al
    The impact of dysfunctional breathing on the assessment of asthma control.
    Respir Med. 2017;123:42-47.
    PubMed     Text format     Abstract available


  16. BJERREGAARD A, Laing IA, Poulsen N, Backer V, et al
    Characteristics associated with clinical severity and inflammatory phenotype of naturally occurring virus-induced exacerbations of asthma in adults.
    Respir Med. 2017;123:34-41.
    PubMed     Text format     Abstract available


  17. COCKLE SM, Stynes G, Gunsoy NB, Parks D, et al
    Comparative effectiveness of mepolizumab and omalizumab in severe asthma: An indirect treatment comparison.
    Respir Med. 2017;123:140-148.
    PubMed     Text format     Abstract available


  18. VARSANO S, Segev D, Shitrit D
    Severe and non-severe asthma in the community: A large electronic database analysis.
    Respir Med. 2017;123:131-139.
    PubMed     Text format     Abstract available


  19. TAKAKU Y, Kurashima K, Ohta C, Ishiguro T, et al
    How many instructions are required to correct inhalation errors in patients with asthma and chronic obstructive pulmonary disease?
    Respir Med. 2017;123:110-115.
    PubMed     Text format     Abstract available


  20. ARMSTRONG HF, Lovasi GS, Soliman EZ, Heckbert SR, et al
    Lung function, percent emphysema, and QT duration: The Multi-Ethnic Study of Atherosclerosis (MESA) lung study.
    Respir Med. 2017;123:1-7.
    PubMed     Text format     Abstract available


    January 2017
  21. ADEYEYE OO, Adewumi TA, Adewuya AO
    Effect of psychological and other factors on quality of life amongst asthma outpatients in Lagos, Nigeria.
    Respir Med. 2017;122:67-70.
    PubMed     Text format     Abstract available


  22. HALLIT S, Raherison C, Waked M, Salameh P, et al
    Validation of asthma control questionnaire and risk factors affecting uncontrolled asthma among the Lebanese children's population.
    Respir Med. 2017;122:51-57.
    PubMed     Text format     Abstract available


    December 2016
  23. CHECKLEY W, Deza MP, Klawitter J, Romero KM, et al
    Identifying biomarkers for asthma diagnosis using targeted metabolomics approaches.
    Respir Med. 2016;121:59-66.
    PubMed     Text format     Abstract available


  24. CHEN JH, Qin L, Shi YY, Feng JT, et al
    IL-17 protein levels in both induced sputum and plasma are increased in stable but not acute asthma individuals with obesity.
    Respir Med. 2016;121:48-58.
    PubMed     Text format     Abstract available


  25. MONTEAGUDO M, Rodriguez-Blanco T, Barrecheguren M, Simonet P, et al
    Prevalence and incidence of bronchiectasis in Catalonia, Spain: A population-based study.
    Respir Med. 2016;121:26-31.
    PubMed     Text format     Abstract available


  26. COMARU T, Pitrez PM, Friedrich FO, Silveira VD, et al
    Free asthma medications reduces hospital admissions in Brazil (Free asthma drugs reduces hospitalizations in Brazil).
    Respir Med. 2016;121:21-25.
    PubMed     Text format     Abstract available


    November 2016
  27. ADACHI M, Goldfrad C, Jacques L, Nishimura Y, et al
    Efficacy and safety comparison: Fluticasone furoate and fluticasone propionate, after step down from fluticasone furoate/vilanterol in Japanese patients with well-controlled asthma, a randomized trial.
    Respir Med. 2016;120:78-86.
    PubMed     Text format     Abstract available


  28. JANSSON SA, Axelsson M, Hedman L, Leander M, et al
    Subjects with well-controlled asthma have similar health-related quality of life as subjects without asthma.
    Respir Med. 2016;120:64-69.
    PubMed     Text format     Abstract available


  29. DEL GIACCO SR, Cappai A, Gambula L, Cabras S, et al
    The asthma-anxiety connection.
    Respir Med. 2016;120:44-53.
    PubMed     Text format     Abstract available


  30. LAHELMA S, Vahteristo M, Metev H, Taseva M, et al
    Equivalent bronchodilation with budesonide/formoterol combination via Easyhaler and Turbuhaler in patients with asthma.
    Respir Med. 2016;120:31-35.
    PubMed     Text format     Abstract available


  31. ALI Z, Nilas L, Ulrik CS
    Low risk of adverse obstetrical and perinatal outcome in pregnancies complicated by asthma: A case control study.
    Respir Med. 2016;120:124-130.
    PubMed     Text format     Abstract available


  32. APIKOGLU-RABUS S, Yesilyaprak G, Izzettin FV
    Drug-related problems and pharmacist interventions in a cohort of patients with asthma and chronic obstructive pulmonary disease.
    Respir Med. 2016;120:109-115.
    PubMed     Text format     Abstract available


  33. LARSEN K, Faulkner GE, Boak A, Hamilton HA, et al
    Looking beyond cigarettes: Are Ontario adolescents with asthma less likely to smoke e-cigarettes, marijuana, waterpipes or tobacco cigarettes?
    Respir Med. 2016;120:10-15.
    PubMed     Text format     Abstract available


    October 2016
  34. ANDRIANOPOULOS V, Celli BR, Franssen FM, Pinto-Plata VM, et al
    Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study.
    Respir Med. 2016;119:87-95.
    PubMed     Text format     Abstract available


  35. ARFE A, Blasi F, Merlino L, Corrao G, et al
    Respiratory drugs and macrolides prevent asthma exacerbations: A real-world investigation.
    Respir Med. 2016;119:7-12.
    PubMed     Text format     Abstract available


  36. ENGELKES M, Janssens HM, de Ridder MA, Sturkenboom MC, et al
    Real life data on incidence and risk factors of severe asthma exacerbations in children in primary care.
    Respir Med. 2016;119:48-54.
    PubMed     Text format     Abstract available


  37. ZIERAU L, Gade EJ, Lindenberg S, Backer V, et al
    Coexistence of asthma and polycystic ovary syndrome: A concise review.
    Respir Med. 2016;119:155-159.
    PubMed     Text format     Abstract available


  38. SPOSATO B, Scalese M, Latorre M, Scichilone N, et al
    Effects of omalizumab in severe asthmatics across ages: A real life Italian experience.
    Respir Med. 2016;119:141-149.
    PubMed     Text format     Abstract available


  39. BELLELLI G, Chalmers JD, Sotgiu G, Dore S, et al
    Characterization of bronchiectasis in the elderly.
    Respir Med. 2016;119:13-19.
    PubMed     Text format     Abstract available


  40. PETHERICK ES, Pearce N, Sunyer J, Wright J, et al
    Ethnic and socio-economic differences in the prevalence of wheeze, severe wheeze, asthma, eczema and medication usage at 4 years of age: Findings from the Born in Bradford birth cohort.
    Respir Med. 2016;119:122-129.
    PubMed     Text format     Abstract available


  41. BRAITHWAITE I, Williams M, Power S, Pilcher J, et al
    Randomised, double-blind, placebo-controlled, cross-over single dose study of the bronchodilator duration of action of combination fluticasone furoate/vilanterol inhaler in adult asthma.
    Respir Med. 2016;119:115-121.
    PubMed     Text format     Abstract available


  42. OCAL S, Portakal O, Ocal A, Demir AU, et al
    Factors associated with pulmonary hypertension and long-term survival in bronchiectasis subjects.
    Respir Med. 2016;119:109-114.
    PubMed     Text format     Abstract available


  43. EFTEKHARI P, Forder PM, Majeed T, Byles JE, et al
    Impact of asthma on mortality in older women: An Australian cohort study of 10,413 women.
    Respir Med. 2016;119:102-108.
    PubMed     Text format     Abstract available


  44. MORI K, Fujisawa T, Inui N, Hashimoto D, et al
    Step-down treatment from medium-dosage of budesonide/formoterol in controlled asthma.
    Respir Med. 2016;119:1-6.
    PubMed     Text format     Abstract available


    September 2016
  45. WESTERHOF GA, de Groot JC, Amelink M, de Nijs SB, et al
    Predictors of frequent exacerbations in (ex)smoking and never smoking adults with severe asthma.
    Respir Med. 2016;118:122-7.
    PubMed     Text format     Abstract available


  46. GRZELA K, Litwiniuk M, Krejner A, Zagorska W, et al
    Increased angiogenic factors in exhaled breath condensate of children with severe asthma - New markers of disease progression?
    Respir Med. 2016;118:119-21.
    PubMed     Text format     Abstract available


  47. DAHL R, Engel M, Dusser D, Halpin D, et al
    Safety and tolerability of once-daily tiotropium Respimat((R)) as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysis.
    Respir Med. 2016;118:102-11.
    PubMed     Text format     Abstract available


  48. BLAIS CM, Davis BE, Cockcroft DW
    Duration of bronchoprotection of the long-acting muscarinic antagonists tiotropium & glycopyrronium against methacholine-induced bronchoconstriction in mild asthmatics.
    Respir Med. 2016;118:96-101.
    PubMed     Text format     Abstract available


  49. KONDLA A, Glaab T, Pedersini R, Lommatzsch M, et al
    Asthma control in patients treated with inhaled corticosteroids and long-acting beta agonists: A population-based analysis in Germany.
    Respir Med. 2016;118:58-64.
    PubMed     Text format     Abstract available


  50. CHAUDHURI R, McSharry C, Heaney LG, Niven R, et al
    Effects of older age and age of asthma onset on clinical and inflammatory variables in severe refractory asthma.
    Respir Med. 2016;118:46-52.
    PubMed     Text format     Abstract available


  51. SELGE C, Thomas S, Nowak D, Radon K, et al
    Asthma prevalence in German Olympic athletes: A comparison of winter and summer sport disciplines.
    Respir Med. 2016;118:15-21.
    PubMed     Text format     Abstract available


  52. SUAREZ-MEDINA R, Venero-Fernandez SJ, Britton J, Fogarty AW, et al
    Population-based weight loss and gain do not explain trends in asthma mortality in Cuba: A prospective study from 1964 to 2014.
    Respir Med. 2016;118:4-6.
    PubMed     Text format     Abstract available


  53. TAN JH, Hsu AA
    Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
    Respir Med. 2016;118:1-3.
    PubMed     Text format     Abstract available


    August 2016
  54. MATULONGA B, Rava M, Siroux V, Bernard A, et al
    Women using bleach for home cleaning are at increased risk of non-allergic asthma.
    Respir Med. 2016;117:264-71.
    PubMed     Text format     Abstract available


  55. BECERRA MB, Becerra BJ, Teodorescu M
    Healthcare burden of obstructive sleep apnea and obesity among asthma hospitalizations: Results from the U.S.-based Nationwide Inpatient Sample.
    Respir Med. 2016;117:230-6.
    PubMed     Text format     Abstract available


  56. TUOMISTO LE, Ilmarinen P, Niemela O, Haanpaa J, et al
    A 12-year prognosis of adult-onset asthma: Seinajoki Adult Asthma Study.
    Respir Med. 2016;117:223-9.
    PubMed     Text format     Abstract available


  57. CRISAFULLI E, Alfieri V, Silva M, Aiello M, et al
    Relationships between emphysema and airways metrics at High-Resolution Computed Tomography (HRCT) and ventilatory response to exercise in mild to moderate COPD patients.
    Respir Med. 2016;117:207-14.
    PubMed     Text format     Abstract available


  58. KERSTJENS HA, Moroni-Zentgraf P, Tashkin DP, Dahl R, et al
    Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status.
    Respir Med. 2016;117:198-206.
    PubMed     Text format     Abstract available


  59. WILSON R, Aksamit T, Aliberti S, De Soyza A, et al
    Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis.
    Respir Med. 2016;117:179-89.
    PubMed     Text format     Abstract available


  60. RADHAKRISHNA N, Tay TR, Hore-Lacy F, Hoy R, et al
    Profile of difficult to treat asthma patients referred for systematic assessment.
    Respir Med. 2016;117:166-73.
    PubMed     Text format     Abstract available


  61. NAQVI M, Khachi H
    The barriers to accessing primary care resulting in hospital presentation for exacerbation of asthma or chronic obstructive pulmonary disease in a large teaching hospital in London.
    Respir Med. 2016;117:162-5.
    PubMed     Text format     Abstract available


  62. LICCARDI G, Salzillo A, Calzetta L, Cazzola M, et al
    Can bronchial asthma with an highly prevalent airway (and systemic) vagal tone be considered an independent asthma phenotype? Possible role of anticholinergics.
    Respir Med. 2016;117:150-3.
    PubMed     Text format     Abstract available


  63. GORSKA K, Korczynski P, Mierzejewski M, Kosciuch J, et al
    Comparison of endobronchial ultrasound and high resolution computed tomography as tools for airway wall imaging in asthma and chronic obstructive pulmonary disease.
    Respir Med. 2016;117:131-8.
    PubMed     Text format     Abstract available


  64. VERMEULEN F, Garcia G, Ninane V, Laveneziana P, et al
    Activity limitation and exertional dyspnea in adult asthmatic patients: What do we know?
    Respir Med. 2016;117:122-30.
    PubMed     Text format     Abstract available


  65. HARTMAN JE, Klooster K, Slebos DJ, Ten Hacken NH, et al
    Improvement of physical activity after endobronchial valve treatment in emphysema patients.
    Respir Med. 2016;117:116-21.
    PubMed     Text format     Abstract available


  66. KOSKELA HO, Purokivi MK, Kokkarinen J
    Stepping down from combination asthma therapy: The predictors of outcome.
    Respir Med. 2016;117:109-15.
    PubMed     Text format     Abstract available


  67. KJELLBERG S, Houltz BK, Zetterstrom O, Robinson PD, et al
    Clinical characteristics of adult asthma associated with small airway dysfunction.
    Respir Med. 2016;117:92-102.
    PubMed     Text format     Abstract available


  68. PAPAIOANNOU AI, Kostikas K, Manali ED, Papadaki G, et al
    Combined pulmonary fibrosis and emphysema: The many aspects of a cohabitation contract.
    Respir Med. 2016;117:14-26.
    PubMed     Text format     Abstract available


    July 2016
  69. SUAREZ-CUARTIN G, Chalmers JD, Sibila O
    Diagnostic challenges of bronchiectasis.
    Respir Med. 2016;116:70-7.
    PubMed     Text format     Abstract available


  70. MIRABELLI MC, Hsu J, Gower WA
    Comorbidities of asthma in U.S. children.
    Respir Med. 2016;116:34-40.
    PubMed     Text format     Abstract available


  71. USMANI OS, Singh D, Spinola M, Bizzi A, et al
    The prevalence of small airways disease in adult asthma: A systematic literature review.
    Respir Med. 2016;116:19-27.
    PubMed     Text format     Abstract available


  72. DIMAKOU K, Triantafillidou C, Toumbis M, Tsikritsaki K, et al
    Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients.
    Respir Med. 2016;116:1-7.
    PubMed     Text format     Abstract available


    June 2016
  73. RADEMACHER J, Ringshausen FC, Suhling H, Fuge J, et al
    Lung transplantation for non-cystic fibrosis bronchiectasis.
    Respir Med. 2016;115:60-5.
    PubMed     Text format     Abstract available


  74. BUHL R, Korn S, Menzies-Gow A, Aubier M, et al
    Assessing biomarkers in a real-world severe asthma study (ARIETTA).
    Respir Med. 2016;115:7-12.
    PubMed     Text format     Abstract available


  75. OHRMALM L, Malinovschi A, Wong M, Levinson P, et al
    Presence of rhinovirus in the respiratory tract of adolescents and young adults with asthma without symptoms of infection.
    Respir Med. 2016;115:1-6.
    PubMed     Text format     Abstract available


    May 2016
  76. HEFFLER E, Crimi N
    Asthma control and bronchodilator response.
    Respir Med. 2016 May 15. pii: S0954-6111(16)30096.
    PubMed     Text format    


  77. RAJAURE Y, Kumar B, Sahoo K, T V, et al
    Bronchodilator response not a significant marker of poor asthma control.
    Respir Med. 2016 May 10. pii: S0954-6111(16)30076.
    PubMed     Text format    


  78. JIANG H, Chi X, Zhang X, Wang J, et al
    Increased serum VDBP as a risk predictor for steroid resistance in asthma patients.
    Respir Med. 2016;114:111-6.
    PubMed     Text format     Abstract available


  79. VAN 'T HUL AJ, Frouws S, van den Akker E, van Lummel R, et al
    Decreased physical activity in adults with bronchial asthma.
    Respir Med. 2016;114:72-7.
    PubMed     Text format     Abstract available


  80. MENDY A, Cohn RD, Thorne PS
    Endotoxin exposure, serum vitamin D, asthma and wheeze outcomes.
    Respir Med. 2016;114:61-6.
    PubMed     Text format     Abstract available


    April 2016
  81. HYRKAS H, Ikaheimo TM, Jaakkola JJ, Jaakkola MS, et al
    Asthma control and cold weather-related respiratory symptoms.
    Respir Med. 2016;113:1-7.
    PubMed     Text format     Abstract available


  82. PATEL MS, Donaldson AV, Lewis A, Natanek SA, et al
    Klotho and smoking--An interplay influencing the skeletal muscle function deficits that occur in COPD.
    Respir Med. 2016;113:50-6.
    PubMed     Text format     Abstract available


  83. JACOB R, Bentur L, Brik R, Shavit I, et al
    Is capnometry helpful in children with bronchiolitis?
    Respir Med. 2016;113:37-41.
    PubMed     Text format     Abstract available


  84. SPIELMANNS M, Gloeckl R, Schmoor C, Windisch W, et al
    Effects on pulmonary rehabilitation in patients with COPD or ILD: A retrospective analysis of clinical and functional predictors with particular emphasis on gender.
    Respir Med. 2016;113:8-14.
    PubMed     Text format     Abstract available


  85. RODRIGUE C, Beauchesne MF, Savaria F, Forget A, et al
    Adverse events among COPD patients treated with long-acting anticholinergics and beta2-agonists in an outpatient respiratory clinic.
    Respir Med. 2016;113:65-73.
    PubMed     Text format     Abstract available


    March 2016
  86. RUTTEN EP
    Comment on "Serum magnesium and not vitamin D is associated with better QoL in COPD: A cross-sectional study".
    Respir Med. 2016;112:130.
    PubMed     Text format    


  87. HUSSEIN SH, Nielsen LP, Dolberg MK, Dahl R, et al
    Response to Dr. Rutten's comment on "Serum magnesium and not vitamin D is associated with better QoL in COPD: A cross-sectional study".
    Respir Med. 2016;112:131.
    PubMed     Text format    


  88. WELTE T, Chapman KR, Magnussen H, Miravitlles M, et al
    Current thinking and new paradigm for COPD.
    Respir Med. 2016;112:126-7.
    PubMed     Text format     Abstract available


  89. ONATIBIA-ASTIBIA A, Martinez-Pinilla E, Franco R
    The potential of methylxanthine-based therapies in pediatric respiratory tract diseases.
    Respir Med. 2016;112:1-9.
    PubMed     Text format     Abstract available


  90. GREEN CE, Parr DG, Edgar RG, Stockley RA, et al
    Lung density associates with survival in alpha 1 antitrypsin deficient patients.
    Respir Med. 2016;112:81-7.
    PubMed     Text format     Abstract available


  91. DISANTOSTEFANO RL, Hinds D, Le HV, Barnes NC, et al
    Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort.
    Respir Med. 2016;112:88-96.
    PubMed     Text format     Abstract available


  92. NIN CS, de Souza VV, do Amaral RH, Schuhmacher Neto R, et al
    Thoracic lymphadenopathy in benign diseases: A state of the art review.
    Respir Med. 2016;112:10-7.
    PubMed     Text format     Abstract available


  93. DONOHUE JF, Singh D, Munzu C, Kilbride S, et al
    Magnitude of umeclidinium/vilanterol lung function effect depends on monotherapy responses: Results from two randomised controlled trials.
    Respir Med. 2016;112:65-74.
    PubMed     Text format     Abstract available


    February 2016
  94. WORTH H, Buhl R, Criee CP, Kardos P, et al
    The 'real-life' COPD patient in Germany: The DACCORD study.
    Respir Med. 2016;111:64-71.
    PubMed     Text format     Abstract available


  95. BARRECHEGUREN M, Monteagudo M, Ferrer J, Borrell E, et al
    Treatment patterns in COPD patients newly diagnosed in primary care. A population-based study.
    Respir Med. 2016;111:47-53.
    PubMed     Text format     Abstract available


  96. ROBERTS NJ, Patel IS, Partridge MR
    The diagnosis of COPD in primary care; gender differences and the role of spirometry.
    Respir Med. 2016;111:60-3.
    PubMed     Text format     Abstract available


  97. WACKER ME, Jorres RA, Schulz H, Heinrich J, et al
    Direct and indirect costs of COPD and its comorbidities: Results from the German COSYCONET study.
    Respir Med. 2016;111:39-46.
    PubMed     Text format     Abstract available


  98. CHECKLEY W, Foreman MG, Bhatt SP, Dransfield MT, et al
    Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease.
    Respir Med. 2016;111:30-8.
    PubMed     Text format     Abstract available


    January 2016
  99. CHALMERS JD, McDonnell MJ, Rutherford R, Davidson J, et al
    The generalizability of bronchiectasis randomized controlled trials: A multicentre cohort study.
    Respir Med. 2016 Jan 29. pii: S0954-6111(16)30012.
    PubMed     Text format     Abstract available


  100. FLAMENT T, Marchand-Adam S, Gatault P, Dupin C, et al
    What are the characteristics of asthma patients with elevated serum IgG4 levels?
    Respir Med. 2016 Jan 22. pii: S0954-6111(16)30011.
    PubMed     Text format     Abstract available


  101. HEFFLER E, Crimi C, Campisi R, Sichili S, et al
    Bronchodilator response as a marker of poor asthma control.
    Respir Med. 2016 Jan 22. pii: S0954-6111(16)30009.
    PubMed     Text format     Abstract available


  102. PANEK M, Mokros L, Pietras T, Kuna P, et al
    The epidemiology of asthma and its comorbidities in Poland - Health problems of patients with severe asthma as evidenced in the Province of Lodz.
    Respir Med. 2016 Jan 20. pii: S0954-6111(16)30005.
    PubMed     Text format     Abstract available


  103. KEMPSFORD RD, Bal J, Baines A, Renaux J, et al
    The efficacy of fluticasone furoate administered in the morning or evening is comparable in patients with persistent asthma.
    Respir Med. 2016 Jan 12. pii: S0954-6111(15)30102.
    PubMed     Text format     Abstract available


  104. PHAM TH, Damera G, Newbold P, Ranade K, et al
    Reductions in eosinophil biomarkers by benralizumab in patients with asthma.
    Respir Med. 2016 Jan 8. pii: S0954-6111(16)30003.
    PubMed     Text format     Abstract available


  105. DONOHUE JF
    Response to Letter to the Editor: Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations.
    Respir Med. 2016;110:81.
    PubMed     Text format    


  106. BANERJI D, Patalano F
    Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations.
    Respir Med. 2016;110:79-80.
    PubMed     Text format    


  107. BOLAND MR, van Boven JF, Kruis AL, Chavannes NH, et al
    Investigating the association between medication adherence and health-related quality of life in COPD: Methodological challenges when using a proxy measure of adherence.
    Respir Med. 2016;110:34-45.
    PubMed     Text format     Abstract available


  108. PRINS HJ, Daniels JM, Lindeman JH, Lutter R, et al
    Effects of doxycycline on local and systemic inflammation in stable COPD patients, a randomized clinical trial.
    Respir Med. 2016;110:46-52.
    PubMed     Text format     Abstract available


  109. MAIO S, Baldacci S, Carrozzi L, Pistelli F, et al
    Respiratory symptoms/diseases prevalence is still increasing: a 25-yr population study.
    Respir Med. 2016;110:58-65.
    PubMed     Text format     Abstract available


  110. JARENBACK L, Ankerst J, Bjermer L, Tufvesson E, et al
    Acinar ventilation heterogeneity in COPD relates to diffusion capacity, resistance and reactance.
    Respir Med. 2016;110:28-33.
    PubMed     Text format     Abstract available


    December 2015
  111. KALLIOLA S, Malmberg LP, Pelkonen AS, Makela MJ, et al
    Aberrant small airways function relates to asthma severity in young children.
    Respir Med. 2015 Dec 19. pii: S0954-6111(15)30097.
    PubMed     Text format     Abstract available


  112. BACKER V, Baines KJ, Powell H, Porsbjerg C, et al
    Increased asthma and adipose tissue inflammatory gene expression with obesity and Inuit migration to a western country.
    Respir Med. 2015 Dec 19. pii: S0954-6111(15)30094.
    PubMed     Text format     Abstract available


  113. POLVERINO E, Torres A, Terraneo S
    Community acquired pneumonia in asthma: Not a threatening combination.
    Respir Med. 2015 Dec 8. pii: S0954-6111(15)00335.
    PubMed     Text format    


    November 2015
  114. ERBABACAN E, M Koksal G, Esquinas AM
    Severity of community acquired pneumonia in asthma patients. How and what are linked?
    Respir Med. 2015 Nov 27. pii: S0954-6111(15)00334.
    PubMed     Text format    


  115. LIU H, Xu C, Jiang ZY, Gu A, et al
    Association of polycyclic aromatic hydrocarbons and asthma among children 6-19 years: NHANES 2001-2008 and NHANES 2011-2012.
    Respir Med. 2015 Nov 10. pii: S0954-6111(15)30084.
    PubMed     Text format     Abstract available


  116. AALBERS R, Vogelmeier C, Kuna P
    Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention.
    Respir Med. 2015 Nov 6. pii: S0954-6111(15)30083.
    PubMed     Text format     Abstract available


  117. DEKHUIJZEN PN
    Guidance on handheld inhalers in asthma and COPD guidelines: An update.
    Respir Med. 2015 Nov 3. pii: S0954-6111(15)30081.
    PubMed     Text format    


    October 2015
  118. DJUKANOVIC R, Hanania N, Busse W, Price D, et al
    IgE-mediated asthma: New revelations and future insights.
    Respir Med. 2015 Oct 30. pii: S0954-6111(15)30077.
    PubMed     Text format     Abstract available


  119. WURST KE, Kelly-Reif K, Bushnell GA, Pascoe S, et al
    Understanding asthma-chronic obstructive pulmonary disease overlap syndrome.
    Respir Med. 2015 Oct 9. pii: S0954-6111(15)30068.
    PubMed     Text format     Abstract available


    September 2015
  120. GALLI JA, Criner GJ
    Author reply: Home non-invasive mechanical ventilation use following acute hypercapnic respiratory failure in COPD. A solid protective factor.
    Respir Med. 2015;109:1234.
    PubMed     Text format    


  121. MATOS P, Kampelmacher MJ, Esquinas AM
    Home non-invasive mechanical ventilation use following acute hypercapnic respiratory failure in COPD. A solid protective factor.
    Respir Med. 2015;109:1233.
    PubMed     Text format    


    July 2015
  122. MARKS-KONCZALIK J, Costa M, Robertson J, McKie E, et al
    A post-hoc subgroup analysis of data from a six month clinical trial comparing the efficacy and safety of losmapimod in moderate-severe COPD patients with </=2% and >2% blood eosinophils.
    Respir Med. 2015;109:860-9.
    PubMed     Text format     Abstract available


  123. DONOHUE JF, Worsley S, Zhu CQ, Hardaker L, et al
    Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations.
    Respir Med. 2015;109:870-81.
    PubMed     Text format     Abstract available


  124. ROTTENKOLBER M, Voogd E, van Dijk L, Primatesta P, et al
    Seasonal changes in prescribing of long-acting beta-2-agonists-containing drugs.
    Respir Med. 2015;109:828-37.
    PubMed     Text format     Abstract available


  125. ROSSI A, Aisanov Z, Avdeev S, Di Maria G, et al
    Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD.
    Respir Med. 2015;109:785-802.
    PubMed     Text format     Abstract available


    June 2015
  126. BRUSSE-KEIZER M, Zuur-Telgen M, van der Palen J, VanderValk P, et al
    Adrenomedullin optimises mortality prediction in COPD patients.
    Respir Med. 2015;109:734-42.
    PubMed     Text format     Abstract available


  127. MCDOUGALL CM, Helms PJ, Walsh GM
    Airway epithelial cytokine responses in childhood wheeze are independent of atopic status.
    Respir Med. 2015;109:689-700.
    PubMed     Text format     Abstract available


  128. HASHIM ALI HUSSEIN S, Nielsen LP, Konow Bogebjerg Dolberg M, Dahl R, et al
    Serum magnesium and not vitamin D is associated with better QoL in COPD: A cross-sectional study.
    Respir Med. 2015;109:727-33.
    PubMed     Text format     Abstract available


  129. MCDONNELL MJ, Jary HR, Perry A, MacFarlane JG, et al
    Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance.
    Respir Med. 2015;109:716-26.
    PubMed     Text format     Abstract available


    May 2015
  130. CANTOR J, Armand G, Turino G
    Lung hyaluronan levels are decreased in alpha-1 antiprotease deficiency COPD.
    Respir Med. 2015;109:656-9.
    PubMed     Text format     Abstract available


  131. MALEKI-YAZDI MR, Beck E, Hamilton AL, Korducki L, et al
    A randomised, placebo-controlled, Phase II, dose-ranging trial of once-daily treatment with olodaterol, a novel long-acting beta2-agonist, for 4 weeks in patients with chronic obstructive pulmonary disease.
    Respir Med. 2015;109:596-605.
    PubMed     Text format     Abstract available


  132. MARTH K, Schuller E, Pohl W
    Improvements in patient-reported outcomes: A prospective, non-interventional study with aclidinium bromide for treatment of COPD.
    Respir Med. 2015;109:616-24.
    PubMed     Text format     Abstract available


  133. JOOS GF, Aumann JL, Coeck C, Korducki L, et al
    A randomised, double-blind, four-way, crossover trial comparing the 24-h FEV1 profile for once-daily versus twice-daily treatment with olodaterol, a novel long-acting beta2-agonist, in patients with chronic obstructive pulmonary disease.
    Respir Med. 2015;109:606-15.
    PubMed     Text format     Abstract available


    April 2015
  134. AYDEMIR Y
    Assessment of the factors affecting the failure to use inhaler devices before and after training.
    Respir Med. 2015;109:451-8.
    PubMed     Text format     Abstract available


  135. HERNANDEZ C, Aibar J, de Batlle J, Gomez-Cabrero D, et al
    Assessment of health status and program performance in patients on long-term oxygen therapy.
    Respir Med. 2015;109:500-9.
    PubMed     Text format     Abstract available


  136. CASTILLO D, Burgos F, Guayta R, Giner J, et al
    Airflow obstruction case finding in community-pharmacies: a novel strategy to reduce COPD underdiagnosis.
    Respir Med. 2015;109:475-82.
    PubMed     Text format     Abstract available


  137. SORRELLS S, Camprubi S, Griffin R, Chen J, et al
    SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.
    Respir Med. 2015;109:490-9.
    PubMed     Text format     Abstract available


  138. OLIVEIRA CC, McGinley J, Lee AL, Irving LB, et al
    Fear of falling in people with chronic obstructive pulmonary disease.
    Respir Med. 2015;109:483-9.
    PubMed     Text format     Abstract available


    March 2015
  139. WANG W, Ying Y, Wu Q, Zhang H, et al
    A GIS-based spatial correlation analysis for ambient air pollution and AECOPD hospitalizations in Jinan, China.
    Respir Med. 2015;109:372-8.
    PubMed     Text format     Abstract available


  140. KAWAGOSHI A, Kiyokawa N, Sugawara K, Takahashi H, et al
    Effects of low-intensity exercise and home-based pulmonary rehabilitation with pedometer feedback on physical activity in elderly patients with chronic obstructive pulmonary disease.
    Respir Med. 2015;109:364-71.
    PubMed     Text format     Abstract available


  141. SUN H, Palcza J, Rosenberg R, Kryger M, et al
    Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease.
    Respir Med. 2015;109:416-26.
    PubMed     Text format     Abstract available


  142. SADATSAFAVI M, Lynd LD, De Vera MA, Zafari Z, et al
    One-year outcomes of inhaled controller therapies added to systemic corticosteroids after asthma-related hospital discharge.
    Respir Med. 2015;109:320-8.
    PubMed     Text format     Abstract available


  143. FAGEVIK OLSEN M, Lannefors L, Westerdahl E
    Positive expiratory pressure - Common clinical applications and physiological effects.
    Respir Med. 2015;109:297-307.
    PubMed     Text format     Abstract available


  144. LIU L, Li G, Sun Y, Li J, et al
    Airway wall thickness of allergic asthma caused by weed pollen or house dust mite assessed by computed tomography.
    Respir Med. 2015;109:339-46.
    PubMed     Text format     Abstract available


    February 2015
  145. MCGARVEY L, Lee AJ, Roberts J, Gruffydd-Jones K, et al
    Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population.
    Respir Med. 2015;109:228-37.
    PubMed     Text format     Abstract available


  146. MURPHY KR, Dhand R, Trudo F, Uryniak T, et al
    Therapeutic equivalence of budesonide/formoterol delivered via breath-actuated inhaler vs pMDI.
    Respir Med. 2015;109:170-9.
    PubMed     Text format     Abstract available


  147. POULSEN PB, Spillemose H, Nielsen G, Hergel LL, et al
    Real-life effectiveness of smoking-cessation treatments in general practice clinics in Denmark. The Escape Smoke project.
    Respir Med. 2015;109:218-27.
    PubMed     Text format     Abstract available


  148. NGUYEN HQ, Rondinelli J, Harrington A, Desai S, et al
    Functional status at discharge and 30-day readmission risk in COPD.
    Respir Med. 2015;109:238-46.
    PubMed     Text format     Abstract available


  149. PEFURA-YONE EW, Fodjeu G, Kengne AP, Roche N, et al
    Prevalence and determinants of chronic obstructive pulmonary disease in HIV infected patients in an African country with low level of tobacco smoking.
    Respir Med. 2015;109:247-54.
    PubMed     Text format     Abstract available


  150. SANCHEZ M, Varraso R, Bousquet J, Clavel-Chapelon F, et al
    Perceived 10-year change in respiratory health: reliability and predictive ability.
    Respir Med. 2015;109:188-99.
    PubMed     Text format     Abstract available


    January 2015
  151. LINDBERG A, Sawalha S, Hedman L, Larsson LG, et al
    Subjects with COPD and productive cough have an increased risk for exacerbations and death.
    Respir Med. 2015;109:88-95.
    PubMed     Text format     Abstract available


  152. LIN J, Kang J, Lee SH, Wang C, et al
    Fluticasone furoate/vilanterol 200/25 mcg in Asian asthma patients: a randomized trial.
    Respir Med. 2015;109:44-53.
    PubMed     Text format     Abstract available


  153. ALTENBURG WA, ten Hacken NH, Bossenbroek L, Kerstjens HA, et al
    Short- and long-term effects of a physical activity counselling programme in COPD: a randomized controlled trial.
    Respir Med. 2015;109:112-21.
    PubMed     Text format     Abstract available


  154. LEE LA, Briggs A, Edwards LD, Yang S, et al
    A randomized, three-period crossover study of umeclidinium as monotherapy in adult patients with asthma.
    Respir Med. 2015;109:63-73.
    PubMed     Text format     Abstract available


  155. LUNDELL S, Holmner A, Rehn B, Nyberg A, et al
    Telehealthcare in COPD: a systematic review and meta-analysis on physical outcomes and dyspnea.
    Respir Med. 2015;109:11-26.
    PubMed     Text format     Abstract available


  156. LEE LA, Yang S, Kerwin E, Trivedi R, et al
    The effect of fluticasone furoate/umeclidinium in adult patients with asthma: a randomized, dose-ranging study.
    Respir Med. 2015;109:54-62.
    PubMed     Text format     Abstract available


  157. JO YS, Choi SM, Lee J, Park YS, et al
    The relationship between chronic obstructive pulmonary disease and comorbidities: a cross-sectional study using data from KNHANES 2010-2012.
    Respir Med. 2015;109:96-104.
    PubMed     Text format     Abstract available


  158. WEDZICHA JA, Buhl R, Lawrence D, Young D, et al
    Monotherapy with indacaterol once daily reduces the rate of exacerbations in patients with moderate-to-severe COPD: Post-hoc pooled analysis of 6 months data from three large phase III trials.
    Respir Med. 2015;109:105-11.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: